187 related articles for article (PubMed ID: 8148155)
1. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.
Hauser S; Weich HA
Growth Factors; 1993; 9(4):259-68. PubMed ID: 8148155
[TBL] [Abstract][Full Text] [Related]
2. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
3. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park JE; Chen HH; Winer J; Houck KA; Ferrara N
J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
[TBL] [Abstract][Full Text] [Related]
4. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
Mamluk R; Gechtman Z; Kutcher ME; Gasiunas N; Gallagher J; Klagsbrun M
J Biol Chem; 2002 Jul; 277(27):24818-25. PubMed ID: 11986311
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.
DiSalvo J; Bayne ML; Conn G; Kwok PW; Trivedi PG; Soderman DD; Palisi TM; Sullivan KA; Thomas KA
J Biol Chem; 1995 Mar; 270(13):7717-23. PubMed ID: 7706320
[TBL] [Abstract][Full Text] [Related]
7. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing.
Cao Y; Ji WR; Qi P; Rosin A; Cao Y
Biochem Biophys Res Commun; 1997 Jun; 235(3):493-8. PubMed ID: 9207183
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
9. VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor.
Terman B; Khandke L; Dougher-Vermazan M; Maglione D; Lassam NJ; Gospodarowicz D; Persico MG; Böhlen P; Eisinger M
Growth Factors; 1994; 11(3):187-95. PubMed ID: 7734144
[TBL] [Abstract][Full Text] [Related]
10. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
Landgren E; Schiller P; Cao Y; Claesson-Welsh L
Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells.
Yang W; Ahn H; Hinrichs M; Torry RJ; Torry DS
J Reprod Immunol; 2003 Oct; 60(1):53-60. PubMed ID: 14568677
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
[TBL] [Abstract][Full Text] [Related]
13. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis.
Yonekura H; Sakurai S; Liu X; Migita H; Wang H; Yamagishi S; Nomura M; Abedin MJ; Unoki H; Yamamoto Y; Yamamoto H
J Biol Chem; 1999 Dec; 274(49):35172-8. PubMed ID: 10575000
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells.
Barleon B; Hauser S; Schöllmann C; Weindel K; Marmé D; Yayon A; Weich HA
J Cell Biochem; 1994 Jan; 54(1):56-66. PubMed ID: 8126087
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected].
Gluzman-Poltorak Z; Cohen T; Herzog Y; Neufeld G
J Biol Chem; 2000 Jun; 275(24):18040-5. PubMed ID: 10748121
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
17. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Deissler HL; Deissler H; Lang GK; Lang GE
Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
[TBL] [Abstract][Full Text] [Related]
18. Placental growth factor induces FosB and c-Fos gene expression via Flt-1 receptors.
Holmes DI; Zachary I
FEBS Lett; 2004 Jan; 557(1-3):93-8. PubMed ID: 14741347
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies.
Helske S; Vuorela P; Carpén O; Hornig C; Weich H; Halmesmäki E
Mol Hum Reprod; 2001 Feb; 7(2):205-10. PubMed ID: 11160848
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 is a placenta growth factor-2 receptor.
Migdal M; Huppertz B; Tessler S; Comforti A; Shibuya M; Reich R; Baumann H; Neufeld G
J Biol Chem; 1998 Aug; 273(35):22272-8. PubMed ID: 9712843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
